At this time, posts about Cha Biotech are rapidly increasing on portals and securities communities, with foreign investors tentatively recorded as net buyers of 6,000 shares today. Cha Biotech is known as a bio company under the Cha Hospital Group.

As of 11:30 AM on the 3rd, Cha Biotech's stock price is 22,150 KRW, down 16.89% from the previous day, with a trading volume of 8,671,554 shares, which is 198.21% of the 5-day average trading volume. On June 2nd, Cha Biotech was a market issue with the news of "surge due to successful clinical treatment of Parkinson's disease."

In addition to Cha Biotech, posts by investors are also rapidly increasing for KNN (058400), Tegoscience (191420), and Ubicare (032620).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing